M. E. Mavi And M. Tuncel, "Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.," Clinical nuclear medicine , vol.46, pp.1002-1003, 2021
Mavi, M. E. And Tuncel, M. 2021. Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.. Clinical nuclear medicine , vol.46 , 1002-1003.
Mavi, M. E., & Tuncel, M., (2021). Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.. Clinical nuclear medicine , vol.46, 1002-1003.
Mavi, Mehmet, And MURAT TUNCEL. "Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.," Clinical nuclear medicine , vol.46, 1002-1003, 2021
Mavi, Mehmet E. And Tuncel, MURAT. "Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.." Clinical nuclear medicine , vol.46, pp.1002-1003, 2021
Mavi, M. E. And Tuncel, M. (2021) . "Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.." Clinical nuclear medicine , vol.46, pp.1002-1003.
@article{article, author={Mehmet Emin Mavi And author={MURAT TUNCEL}, title={Treatment of Glucagonoma-Related Necrolytic Migratory Erythema With Peptide Receptor Radionuclide Therapy.}, journal={Clinical nuclear medicine}, year=2021, pages={1002-1003} }